MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 92 filers reported holding MERUS N V in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,182,365 | -4.6% | 219,778 | +6.5% | 0.00% | – |
| Q2 2023 | $5,433,696 | +2.2% | 206,369 | -28.6% | 0.00% | – |
| Q1 2023 | $5,318,562 | -38.9% | 289,061 | -48.6% | 0.00% | – |
| Q4 2022 | $8,698,316 | +128.7% | 562,270 | +196.1% | 0.00% | – |
| Q3 2022 | $3,804,000 | -9.1% | 189,907 | +2.7% | 0.00% | – |
| Q2 2022 | $4,185,000 | -10.1% | 184,839 | +5.0% | 0.00% | – |
| Q1 2022 | $4,654,000 | -9.6% | 176,031 | +8.7% | 0.00% | – |
| Q4 2021 | $5,151,000 | +101.9% | 161,982 | +39.7% | 0.00% | – |
| Q3 2021 | $2,551,000 | +9.6% | 115,933 | +4.9% | 0.00% | – |
| Q2 2021 | $2,328,000 | +201.6% | 110,467 | +198.8% | 0.00% | – |
| Q1 2021 | $772,000 | +68.6% | 36,972 | +41.5% | 0.00% | – |
| Q4 2020 | $458,000 | +45.4% | 26,137 | -0.5% | 0.00% | – |
| Q3 2020 | $315,000 | +45.2% | 26,268 | +94.9% | 0.00% | – |
| Q2 2020 | $217,000 | – | 13,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |